Table 1 Laboratory results during hospitalization
Laboratory test | Reference range | DOL 1 | DOL 2 | DOL 5 | DOL 8 | DOL 9 | DOL 10 | DOL 11 | DOL 12 |
|---|---|---|---|---|---|---|---|---|---|
Hemoglobin (mmol/L) | 9.5–13 | 10.6 | 12.1 | 9.5 | 11.0 | 9.7 | – | 8.7 | – |
Total leukocyte count (× 109/L) | 10–25 | 20.4 | 9.7 | 4.5 | 7.8 | 8.2 | – | 7.8 | – |
Total lymphocyte count (× 109/L) | 2–12.6 | 7.7 | – | 1.6 | – | 4.3 | – | – | – |
Platelet count (× 109/L) | 150–350 | > 244 | 176 | 89 | 64 | 110 | – | 164 | – |
C-reactive protein (mg/L) | <Â 10 | <Â 4 | 2 | 22 | 1 | 1 | 2 | 51 | 27 |
Ferritin (µg/L) | 200–600 | – | – | – | – | – | 2379 | 1764 | 1057 |
Aspartate aminotransferase (U/L) | < 31 | – | – | – | – | – | 66 | – | – |
Lactate dehydrogenase (U/L) | 150–380 | – | – | – | – | – | 1364 | 838 | – |
d-dimer (µg/L) | < 500 | – | – | – | – | – | 5147 | 1286 | – |
Fibrinogen (g/L) | 1.25–3.0 | – | – | – | – | – | 2.2 | 3.7 | – |
Prothrombin time (s) | 11–14.5 | – | – | – | – | – | 11.2 | – | – |
SARS-CoV-2 total Ig | Neg–Pos | Neg | – | – | – | Pos | – | – | – |
SARS-CoV-2 IgM | Neg–Pos | Neg | – | – | – | Pos | – | – | – |
Cycle threshold (upper respiratory tract) |  | 26 | – | – | 25 | – | – | – | – |
Cycle threshold (sputum) |  | – | – | 13 | – | – | 23 | – | – |